Role of trazodone in treatment of major depressive disorder: an update

Major depressive disorder (MDD) is the most common mood disorder and a leading cause of disability worldwide. Trazodone, a triazolopyridine serotonin receptor antagonist and reuptake inhibitor (SARI) antidepressant approved for major depressive disorder (MDD) in adults, has established efficacy that...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagiolini, Andrea, González-Pinto, Ana, Miskowiak, Kamilla Woznica, Morgado, Pedro, Young, Allan H., Vieta, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474647/
https://www.ncbi.nlm.nih.gov/pubmed/37660092
http://dx.doi.org/10.1186/s12991-023-00465-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474647/
https://www.ncbi.nlm.nih.gov/pubmed/37660092
http://dx.doi.org/10.1186/s12991-023-00465-y

Ejemplares similares